Should You Hold Taysha Gene Therapies Inc (TSHA) Stock Friday Morning?

Taysha Gene Therapies Inc (TSHA) is down Friday morning, with the stock declining -2.90% in pre-market trading to 3.01. TSHA's short-term technical score of 99 indicates that the stock has traded more bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 95 out of 146 industries, TSHA ranks higher than 100% of stocks. Taysha Gene Therapies Inc has risen 44.19% over the past month, closing at $2.50 on February 23. During this period of time, the stock fell as low as $2.13 and as high as $3.55. TSHA has an average analyst recommendation of Strong Buy. The company has an average price target of $7.50.

TSHA has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on TSHA!

See Full TSHA Report

Taysha Gene Therapies Inc has a Long-Term Technical rank of 92. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 8% of the market scoring higher. In the Biotechnology industry which is number 79 by this metric, TSHA ranks better than 79% of stocks.

Important Dates for Investors in TSHA:

-Taysha Gene Therapies Inc is set to release earnings on 2024-05-09. Over the last 12 months, the company has reported EPS of $-2.87. -We do not have a set dividend date for Taysha Gene Therapies Inc at this time. Click Here To Get The Full Report on Taysha Gene Therapies Inc (TSHA)